Vous n'êtes pas identifié (connexion)

Centre de recherche

JEUDI 04 MAI

Dr Nicholas Brousseau et Dre Marie-France Beaudet, Direction de la Santé publique

Séminaire

Les oreillons; toujours d'actualité en 2017

Calendrier >

BOTTIN

Éric Vigneault

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Oncologie
Adresse(s)
Hôtel-Dieu de Québec
11, Côte du Palais, Bureau 3336
Québec (Québec)
CANADA G1R 2J6

Téléphone(s)
+1 418-691-5264
Télécopieur(s)
Courriel(s)
Eric.Vigneault@mail.chudequebec.ca

Projet(s) de recherche reconnu(s) par l'Université Laval

Autre(s) projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Lalani N, Cummings B, Halperin R, Rakovitch E, Brundage M, Vigneault E, Milosevic M. The Practice of Radiation Oncology in Canada. International journal of radiation oncology, biology, physics ,  2017. 97: 876-880
Miksys N, Vigneault E, Martin AG, Beaulieu L, Thomson RM. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy. International journal of radiation oncology, biology, physics ,  2017. 97: 606-615
Vigneault E, Mbodji K, Racine LG, Chevrette E, Lavallee MC, Martin AG, Despres P, Beaulieu L. Image-guided high-dose-rate brachytherapy boost to the dominant intraprostatic lesion using multiparametric magnetic resonance imaging including spectroscopy: Results of a prospective study. Brachytherapy,  2016. Epub
Azad AK, Bairati I, Qiu X, Girgis H, Cheng L, Waggott D, Cheng D, Mirshams M, Ho J, Fortin A, Vigneault E, Huang SH, O'Sullivan B, Waldron J, Boutros PC, Goldstein D, Meyer F, Xu W, Liu G. A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways. Cancer epidemiology,  2016. 42: 173-80
Vigneault E, Savard J, Ivers H, Savard MH, Fradet V, Despres P, Foster W, Martin AG. Validation of a French-Canadian Version of the Expanded Prostate Cancer Index Composite Instrument (EPIC). International journal of radiation oncology, biology, physics ,  2016. 96: E531-E532
Gaudet M, Vigneault E, Foster W, Meyer F, Martin AG. Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,  2016. 118: 141-7
Vigneault E, Mbodji K, Racine LG, Chevrette E, Lavallee MC, Martin AG, Despres P, Beaulieu L. Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy. Cureus,  2016. Epub
Vigneault E, Mbodji K, Beaudet ME, Despres P, Lavallee MC, Martin AG, Foster W, Aubin S, Beaulieu L. Does prostate volume has an impact on biochemical failure in patients with localized prostate cancer treated with HDR boost? Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,  2016. Epub
Saad F, Chi KN, Finelli A, Hotte SJ, Izawa J, Kapoor A, Kassouf W, Loblaw A, North S, Rendon R, So A, Usmani N, Vigneault E, Fleshner NE. The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC). Canadian Urological Association journal = Journal de l’Association des urologues du Canada.,  2015. 9: 90-6
Smith GD, Pickles T, Crook J, Martin AG, Vigneault E, Cury FL, Morris J, Catton C, Lukka H, Warner A, Yang Y, Rodrigues G. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis. International journal of radiation oncology, biology, physics ,  2015. 91: 505-16
© 2017 Tous droits réservés Centre de recherche du CHU de Québec